Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Natural substance protects nerve cells from the damage caused by neurodegenerative diseases

University of Tübingen research team investigates bacteria-made agent which may counter the damage of Alzheimer´s disease.

6 Oct 2021

Cancer drug can restore memory and cognitive function in mice with Alzheimer’s symptoms

A drug commonly used to treat cancer can restore memory and cognitive function in mice that display symptoms of Alzheimer's disease, new UBC research has found.

5 Oct 2021

Plant-derived compound can be beneficial in protecting the brain against Alzheimer’s disease pathology

Fenchol, a natural compound abundant in some plants including basil, can help protect the brain against Alzheimer's disease pathology, a preclinical study led by University of South Florida Health (USF Health) researchers suggests.

5 Oct 2021

$35.1 million US grant focuses on investigating sleep disorder linked to neurodegeneration

People with rapid eye movement (REM) sleep behavior disorder act out their dreams. While sleeping safely in bed, for example, they might throw up their arms to catch an imaginary ball, or try to run from an illusory assailant.

5 Oct 2021

MR study finds no causal link between age at menarche or age at menopause and Alzheimer's risk

Aging-US published "The role of age at menarche and age at menopause in Alzheimer's disease: evidence from a bidirectional mendelian randomization study" which reported that the association between endogenous estrogen exposure and Alzheimer's disease remains inconclusive in previous observational studies, and few Mendelian randomization studies have focused on their causality thus far.

5 Oct 2021

Early intervention to delay the onset of hypertension may help prevent dementia

Individuals who are diagnosed with high blood pressure at ages 35-44 had smaller brain size and were more likely to develop dementia compared to people who had normal blood pressure, according to new research published today in Hypertension, an American Heart Association journal.

4 Oct 2021

Early accumulation of tau proteins in the brain more effective at predicting memory impairment

Researchers at Karolinska Institutet in Sweden have compared how well different Alzheimer's biomarkers predict the progression of the disease and its effect on memory.

1 Oct 2021

Study finds no link between menopausal hormone therapy and increased risk of dementia

Use of menopausal hormone therapy (MHT, also known as hormone replacement therapy, HRT) is not associated with an increased risk of developing dementia, regardless of hormone type, dose, or duration, concludes a large UK study published by The BMJ.

30 Sep 2021

Wiggling worms offer new clues into the potential impact of diet on Alzheimer's

Worms don't wiggle when they have Alzheimer's disease. Yet something helped worms with the disease hold onto their wiggle in Professor Jessica Tanis's lab at the University of Delaware.

29 Sep 2021

Buck Institute receives $14 million NIH grant to focus on one of the major drivers of aging

Buck Institute professors Judith Campisi, PhD and Lisa Ellerby PhD, have been awarded a $14.3 million grant from the NIH's National Institute of Aging to study cellular senescence, one of the major hallmarks of aging, as a driver of Alzheimer's disease and other age-related dementias.

29 Sep 2021

Alzheimer’s drug targets people with mild cognitive impairment. What does that mean?

The approval of a controversial new drug for Alzheimer's disease, Aduhelm, is shining a spotlight on mild cognitive impairment — problems with memory, attention, language or other cognitive tasks that exceed changes expected with normal aging.

29 Sep 2021

Researchers develop new mouse model for studying non-Demented with Alzheimer’s disease

Alzheimer's is a neurodegenerative disease that features the accumulation of the beta-amyloid peptide and Tau protein in the brain, which are associated with deficits in the neuronal connections and with dementia.

28 Sep 2021

Depression in early adulthood may lead to cognitive decline in old age

While research has shown that poor cardiovascular health can damage blood flow to the brain increasing the risk for dementia, a new study led by UC San Francisco indicates that poor mental health may also take its toll on cognition.

28 Sep 2021

UNLV neuroscientists bolster the connection between Type II diabetes and Alzheimer's disease

A team of UNLV neuroscientists has strengthened the link between Type II diabetes and Alzheimer's disease.

28 Sep 2021

Brain communication networks altered during drug withdrawal, mice study shows

Zeroing in on specific brain regions when studying drug and alcohol abuse simplifies research but may leave out important insights.

27 Sep 2021

Inexpensive anti-seizure drug benefits Alzheimer's patients with silent epileptic activity

An inexpensive anti-seizure medication markedly improves learning and memory and other cognitive functions in Alzheimer's patients who have epileptic activity in their brains, according to a study published in the Sept. 27th issue of JAMA Neurology.

27 Sep 2021

New blood test to diagnose Alzheimer's disease using atomic force microscopy

If the suspicion of Alzheimer's disease creeps up, those affected must prepare themselves for lengthy and complex procedures until the case is clear.

27 Sep 2021

Researchers discover how Rift Valley fever virus enters cells

Rift Valley fever virus causes economically devastating outbreaks of hemorrhagic fever in livestock such as sheep, goats and cattle.

24 Sep 2021

NIH-funded project to test light therapies to combat Alzheimer’s debilitating effects

Alzheimer's disease is a mind-robbing brain disorder that affects nearly 6.2 million older Americans. Despite decades of research on high-tech drugs, diets, and crossword puzzles, scientists have yet to discover a highly effective treatment for patients.

23 Sep 2021

Study provides clearer understanding of how migraines affect sleep patterns

Adults and children with migraines may get less quality, REM sleep time than people who don't have migraines.

23 Sep 2021

Alzheimer's Disease News and Research

Further Reading

Natural substance protects nerve cells from the damage caused by neurodegenerative diseases

Cancer drug can restore memory and cognitive function in mice with Alzheimer’s symptoms

Plant-derived compound can be beneficial in protecting the brain against Alzheimer’s disease pathology

$35.1 million US grant focuses on investigating sleep disorder linked to neurodegeneration

MR study finds no causal link between age at menarche or age at menopause and Alzheimer's risk

Early intervention to delay the onset of hypertension may help prevent dementia

Early accumulation of tau proteins in the brain more effective at predicting memory impairment

Study finds no link between menopausal hormone therapy and increased risk of dementia

Wiggling worms offer new clues into the potential impact of diet on Alzheimer's

Buck Institute receives $14 million NIH grant to focus on one of the major drivers of aging

Alzheimer’s drug targets people with mild cognitive impairment. What does that mean?

Researchers develop new mouse model for studying non-Demented with Alzheimer’s disease

Depression in early adulthood may lead to cognitive decline in old age

UNLV neuroscientists bolster the connection between Type II diabetes and Alzheimer's disease

Brain communication networks altered during drug withdrawal, mice study shows

Inexpensive anti-seizure drug benefits Alzheimer's patients with silent epileptic activity

New blood test to diagnose Alzheimer's disease using atomic force microscopy

Researchers discover how Rift Valley fever virus enters cells

NIH-funded project to test light therapies to combat Alzheimer’s debilitating effects

Study provides clearer understanding of how migraines affect sleep patterns

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News